OBJECTIVE: To report the surgical treatment of @entity1 with @entity1358 ( @entity1358 ) metastatic to the contralateral adrenal gland and compare our experience with previous reports, as such metastases are found in 2.5% of @entity1 with metastatic @entity1358 at autopsy, and the role of resecting metastatic @entity1358 at this site is not well defined. @entity1 AND METHODS: We retrospectively identified 11 @entity1 who had surgery for metastatic @entity1358 to the contralateral adrenal gland between October 1978 and April 2001. The @entity1 ' medical records were reviewed for clinical, surgical and pathological features, and the @entity1 ' outcome. RESULTS: The mean (median, range) age of the @entity1 at primary nephrectomy was 60.9 (64, 43-79) years; all had clear cell (conventional) @entity1358 . Synchronous contralateral adrenal metastasis occurred in two @entity1 . The mean (median, range) time to contralateral adrenal metastasis after primary nephrectomy for the remaining nine @entity1 was 5.2 (6.1, 0.8-9.2) years. All @entity1 were treated with adrenalectomy; there were no perioperative complications or mortality. Seven @entity1 died from @entity1358 at a mean (median, range) of 3.9 (3.7, 0.2-10) years after adrenalectomy for contralateral adrenal metastasis; one died from other causes at 3.4 years, one from an unknown cause at 1.7 years and two were still alive at the last follow-up. CONCLUSIONS: The surgical resection of contralateral adrenal metastasis from @entity1358 is safe; although most @entity1 died from @entity1358 , survival may be prolonged in individual @entity1 . Hence, in the era of cytoreductive surgery, the removal of solitary contralateral adrenal metastasis seems to be indicated.

Contralateral adrenal metastasis of XXXX : treatment, outcome and a review.

@entity1 :: ('9606', 'Species') :: ['patients', 'PATIENTS'] @entity1358 :: ('MESH:D002292', 'Disease') :: ['renal cell carcinoma', 'RCC']
@entity1358 :: (MESH:D002292,Disease) :: ['renal cell carcinoma']
